工银瑞信中证创新药产业ETF(516060)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
12,685,617.05 |
-21,549,322.12 |
-37,321,081.89 |
-15,628,201.79 |
| 利息合计 |
4,557.08 |
12,409.00 |
5,830.80 |
15,859.08 |
| 其中：存款利息收入 |
4,557.08 |
12,409.00 |
5,830.80 |
15,859.08 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-12,731,651.99 |
-21,766,773.11 |
-12,036,412.54 |
-10,286,104.06 |
| 其中：股票投资收益 |
-13,547,297.93 |
-23,701,793.17 |
-13,160,078.97 |
-11,607,072.06 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
815,645.94 |
1,935,020.06 |
1,123,666.43 |
1,320,968.00 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
25,381,834.36 |
193,432.61 |
-25,339,154.24 |
-5,503,714.75 |
| 其他收入 |
30,877.60 |
11,609.38 |
48,654.09 |
145,757.94 |
| 费用 |
435,365.02 |
981,044.05 |
481,727.77 |
934,010.25 |
| 管理人报酬 |
242,523.86 |
578,288.09 |
274,871.44 |
557,316.52 |
| 基金托管费 |
37,725.97 |
89,955.96 |
42,757.85 |
86,693.73 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
155,115.19 |
312,800.00 |
164,098.48 |
290,000.00 |
| 利润总额 |
12,250,252.03 |
-22,530,366.17 |
-37,802,809.66 |
-16,562,212.04 |
微信公众号
证券之星APP
基本资料
